These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33562278)

  • 1. Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys.
    Miyamoto K; Ishibashi Y; Akita T; Yamashita C
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.
    Miyamoto K; Akita T; Yamashita C
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory.
    Miyamoto K; Yanagisawa M; Taga H; Yamaji H; Akita T; Yamashita C
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33946783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ghrelin on growth hormone secretion from cultured adenohypophysial cells in cattle.
    Hashizume T; Horiuchi M; Tate N; Nonaka S; Kojima M; Hosoda H; Kangawa K
    Endocr J; 2003 Jun; 50(3):289-95. PubMed ID: 12940457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ghrelin on growth hormone secretion from cultured adenohypophysial cells in pigs.
    Hashizume T; Horiuchi M; Tate N; Nonaka S; Mikami U; Kojima M
    Domest Anim Endocrinol; 2003 Apr; 24(3):209-18. PubMed ID: 12642161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
    Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient optimization of high-dose formulation of novel lyophilizates for dry powder inhalation by the combination of response surface methodology and time-of-flight measurement.
    Ohori R; Kiuchi S; Sugiyama S; Miyamoto K; Akita T; Yamashita C
    Int J Pharm; 2020 May; 581():119255. PubMed ID: 32217154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery.
    Salade L; Wauthoz N; Vermeersch M; Amighi K; Goole J
    Eur J Pharm Biopharm; 2018 Aug; 129():257-266. PubMed ID: 29902517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a dry powder inhaler, the Ultrahaler, containing triamcinolone acetonide using in vitro-in vivo relationships.
    Lim JG; Shah B; Rohatagi S; Bell A
    Am J Ther; 2006; 13(1):32-42. PubMed ID: 16428920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats.
    Onoue S; Aoki Y; Matsui T; Kojo Y; Misaka S; Mizumoto T; Yamada S
    Int J Pharm; 2011 May; 410(1-2):54-60. PubMed ID: 21419198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.
    Miyamoto K; Taga H; Akita T; Yamashita C
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T; Misra A
    Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
    Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
    Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies.
    Viswanathan V; Pharande R; Bannalikar A; Gupta P; Gupta U; Mukne A
    Drug Dev Ind Pharm; 2019 Jan; 45(1):11-20. PubMed ID: 30122088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.
    Qiu Y; Man RCH; Liao Q; Kung KLK; Chow MYT; Lam JKW
    J Control Release; 2019 Nov; 314():102-115. PubMed ID: 31629037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.